Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

NCT03636438 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Ornithine Transcarbamylase (OTC) Deficiency

Interventions

OTHER: No Intervention

Sponsor

Ultragenyx Pharmaceutical Inc